Literature DB >> 11747090

Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopy.

Y Wakayama1, M Inoue, H Kojima, M Murahashi, S Shibuya, H Oniki.   

Abstract

In order to investigate the mode of existence of the sarcoglycan complex, neuronal nitric oxide synthase (nNOS), beta-dystroglycan, and dystrophin in the normal skeletal myofiber, we examined the ultrastructural localization and mutual spatial relationship of nNOS, beta-dystroglycan, dystrophin, and the individual components of the sarcoglycan complex by using triple immunogold labeling electron microscopy. Each molecule of alpha-, beta-, gamma- and delta-sarcoglycans is located intracellularly or extracellularly near the muscle plasma membrane mostly in accordance with the sarcoglycan antigenic sites against which the antibodies were generated. The association of different two and/or three sarcoglycan molecules out of alpha-, beta-, gamma- and delta-sarcoglycan molecules was frequently observed. Each molecule of nNOS, beta-dystroglycan, and dystrophin was ultrastructurally noted along the cell surface of normal skeletal myofibers. Moreover, the close relation of a sarcoglycan molecule with beta-dystroglycan and dystrophin, and the association of nNOS with dystrophin were also confirmed ultrastructurally. Thus, this study demonstrated that the constituting molecules of the sarcoglycan complex, nNOS, beta-dystroglycan, and dystrophin existed in the form of a cluster at the normal muscle plasma membrane. The association of nNOS with dystrophin and its associated glycoproteins may form a macromolecular signaling complex at the muscle plasma membrane. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747090     DOI: 10.1002/jemt.1166

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  6 in total

1.  Biophysical Stimulation for Engineering Functional Skeletal Muscle.

Authors:  Sarah M Somers; Alexander A Spector; Douglas J DiGirolamo; Warren L Grayson
Journal:  Tissue Eng Part B Rev       Date:  2017-08       Impact factor: 6.389

2.  A simple solution for antibody signal enhancement in immunofluorescence and triple immunogold assays.

Authors:  Abraham Rosas-Arellano; Juan B Villalobos-González; Lourdes Palma-Tirado; Felipe A Beltrán; Alfonso Cárabez-Trejo; Fanis Missirlis; Maite A Castro
Journal:  Histochem Cell Biol       Date:  2016-05-17       Impact factor: 4.304

3.  SynCAM, a novel putative tumor suppressor, suppresses growth and invasiveness of glioblastoma.

Authors:  Xiaoju Zhang; Wei Li; Yi Kang; Jianguo Zhang; Huijuan Yuan
Journal:  Mol Biol Rep       Date:  2013-08-02       Impact factor: 2.316

4.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

5.  Fukutin-related protein resides in the Golgi cisternae of skeletal muscle fibres and forms disulfide-linked homodimers via an N-terminal interaction.

Authors:  Maisoon Alhamidi; Elisabeth Kjeldsen Buvang; Toril Fagerheim; Vigdis Brox; Sigurd Lindal; Marijke Van Ghelue; Øivind Nilssen
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

6.  Downregulating SynCAM and MPP6 expression is associated with ovarian cancer progression.

Authors:  Feixue Xu; Xiaoqiang Si; Jingran Du; Feihua Xu; Aihong Yang; Caixia Zhang; Xiucai Zhang; Yongxiu Yang
Journal:  Oncol Lett       Date:  2019-06-28       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.